Form 4: P3 Health Partners Director Mary Tolan Acquires Stock Options

Sentiment:

SEC Form 4 Filing


Director Mary Tolan acquired stock options in P3 Health Partners Inc. on June 6, 2024, according to a recent SEC Form 4 filing.

Summary

  • Mary Tolan, a director of P3 Health Partners Inc., acquired 482,640 stock options on June 6, 2024.
  • The exercise price of these options is $0.5461.
  • The options vest on the earlier of June 6, 2025, or the date of the next annual meeting of the Issuer's stockholders, contingent upon continued service.
  • A Power of Attorney was executed on July 30, 2021, granting Aric Coffman, Leslie Fisher, and Atul Kavthekar the authority to act on Mary Tolan's behalf for SEC filings related to P3 Health Partners Inc.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance.

Industry Context

This filing is a routine disclosure related to insider transactions, which is common in the healthcare industry. It provides transparency regarding the holdings of company insiders.

Stakeholder Impact

  • The acquisition of stock options by a director could be viewed positively by shareholders as it aligns the director's interests with the company's long-term success.

Key Dates

DateDescription
2021-07-30Date of execution of Power of Attorney.
2024-06-06Date of transaction: acquisition of stock options.
2024-06-10Date of filing of the Form 4.
2025-06-06Earliest vesting date for the stock options.
2034-06-06Expiration date for the stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.